Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Peter de Keizer's pioneering research at Erasmus University Medical Center to its current status as a leading senolytic research tool, FOXO4-DRI demonstrates how precise molecular targeting can enable selective elimination of harmful cellular populations while preserving healthy tissue function
GHK-Cu side effects at clinical doses are generally mild
J Pharmacol Exp Ther 1995;272(1):417-422
This allows controlled, repeated access from a single multi-dose vial within the validated use window
In stock Ships same day before 3:00 PM CST Volume discount 3 vials 3% off Popular 5 vials 5% off Best value 10 vials 10% off You'll earn 34 reward points with this order Add to unlock off Overnight shipping available Calculating
Do not microwave, run under hot water, or heat aggressively
US$ 20.81
US$ 24.15
US$ 23.17
US$ 25.76
US$ 26.59
US$ 22.28
US$ 28.06
